Botanix Pharmaceuticals (ASX:BOT) launches Phase 2 BTX 1801 study for SSIs

Botanix Pharmaceuticals (BOT) has launched the second phase of its BTX 1801 … Continue reading Botanix Pharmaceuticals (ASX:BOT) launches Phase 2 BTX 1801 study for SSIs